{"name":"CureVac","permalink":"curevac","crunchbase_url":"http://www.crunchbase.com/company/curevac","homepage_url":"http://www.curevac.com","blog_url":"","blog_feed_url":"","twitter_username":"","category_code":"biotech","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"deadpooled_year":null,"deadpooled_month":null,"deadpooled_day":null,"deadpooled_url":null,"tag_list":"","alias_list":"","email_address":"info@curevac.com","phone_number":"49(0)-70-71-9-20-53-0","description":"","created_at":"Tue Apr 20 07:10:36 UTC 2010","updated_at":"Tue Sep 18 10:14:59 UTC 2012","overview":"<p>CureVac GmbH is a biopharmaceutical company specializing in the prophylactic and\ntherapeutic  application of  messenger RNA  (mRNA). CureVac&amp;apos;s  lead programme is dedicated  to the development of active  immunotherapies (based on its RNActiveÂ® technology) for the treatment of prostate cancer and non-small cell lung cancer. Furthermore, in preclinical studies, CureVac is developing prophylactic vaccines and adjuvants to address infectious diseases.</p>","image":{"available_sizes":[[[150,56],"assets/images/resized/0008/4249/84249v1-max-150x150.jpg"],[[178,67],"assets/images/resized/0008/4249/84249v1-max-250x250.jpg"],[[178,67],"assets/images/resized/0008/4249/84249v1-max-450x450.jpg"]],"attribution":null},"products":[],"relationships":[],"competitions":[],"providerships":[],"total_money_raised":"€137M","funding_rounds":[{"round_code":"b","source_url":"http://www.curevac.com/news_archive.php?uid=12&lang=en","source_description":"New round of financing for CureVac GmbH Euro 22 million for cancer research and treatment","raised_amount":22000000,"raised_currency_code":"EUR","funded_year":2006,"funded_month":1,"funded_day":18,"investments":[{"company":null,"financial_org":{"name":"DH Capital","permalink":"dh-capital","image":{"available_sizes":[[[115,61],"assets/images/resized/0006/1890/61890v1-max-150x150.png"],[[115,61],"assets/images/resized/0006/1890/61890v1-max-250x250.png"],[[115,61],"assets/images/resized/0006/1890/61890v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"OH Beteiligungen","permalink":"oh-beteiligungen","image":null},"person":null}]},{"round_code":"c","source_url":"http://onbiovc.com/curevac-gmbh-series-c-349m/","source_description":"CureVac, GmbH: Series C $34.9M","raised_amount":34900000,"raised_currency_code":"USD","funded_year":2010,"funded_month":5,"funded_day":10,"investments":[{"company":null,"financial_org":{"name":"dievini Hopp Biotech Holding","permalink":"dievini-hopp-biotech-holding","image":{"available_sizes":[[[150,44],"assets/images/resized/0010/1829/101829v1-max-150x150.jpg"],[[250,73],"assets/images/resized/0010/1829/101829v1-max-250x250.jpg"],[[284,84],"assets/images/resized/0010/1829/101829v1-max-450x450.jpg"]],"attribution":null}},"person":null}]},{"round_code":"d","source_url":"http://www.prnewswire.com/news-releases/curevac-secures-eur80-million-in-series-d-financing-170137536.html","source_description":"CureVac Secures EUR80 Million in Series D Financing","raised_amount":80000000,"raised_currency_code":"EUR","funded_year":2012,"funded_month":9,"funded_day":18,"investments":[{"company":null,"financial_org":{"name":"dievini Hopp Biotech Holding","permalink":"dievini-hopp-biotech-holding","image":{"available_sizes":[[[150,44],"assets/images/resized/0010/1829/101829v1-max-150x150.jpg"],[[250,73],"assets/images/resized/0010/1829/101829v1-max-250x250.jpg"],[[284,84],"assets/images/resized/0010/1829/101829v1-max-450x450.jpg"]],"attribution":null}},"person":null}]}],"investments":[],"acquisition":null,"acquisitions":[],"offices":[{"description":"","address1":"Paul-Ehrlich-Str. 15","address2":"","zip_code":"72076","city":"TÃ¼bingen","state_code":null,"country_code":"DEU","latitude":null,"longitude":null}],"milestones":[],"ipo":null,"video_embeds":[],"screenshots":[{"available_sizes":[[[150,96],"assets/images/resized/0008/4250/84250v1-max-150x150.jpg"],[[250,161],"assets/images/resized/0008/4250/84250v1-max-250x250.jpg"],[[450,290],"assets/images/resized/0008/4250/84250v1-max-450x450.jpg"]],"attribution":null}],"external_links":[]}